“Microplastics create medical issues in humans”

Microplastics are ubiquitous environmental contaminants, and numerous studies confirm their presence in human tissues and fluids, including the placenta, blood, lungs, and gut. While direct, high-quality human clinical trials are lacking, a growing body of evidence from systematic reviews and meta-analyses of observational studies suggests that microplastics may contribute to various medical issues.

Specifically, a meta-analysis of human studies found a significant correlation between microplastic content in the placenta and shorter gestational age and a five-fold increased risk of intrauterine growth restriction. Other human observational studies have reported associations between placental microplastics and reduced birthweights and lower Apgar scores. Broader systematic reviews indicate that microplastic exposure is suspected to adversely impact human reproductive, digestive, and respiratory health, with potential links to colon and lung cancer, although the quality of human evidence for these broader claims is often rated as moderate to low.

Supporting these observations, extensive research in cell cultures and animal models demonstrates that microplastics can induce a range of harmful biological effects. These include oxidative stress, inflammation, cellular damage, genotoxicity, disruption of internal barriers (such as in the gut and lungs), and adverse effects on reproductive and developmental processes. These mechanistic findings provide a plausible biological basis for the potential health concerns observed in humans.

Despite these findings, the overall evidence base for direct causation of a wide array of medical issues in humans remains limited. Most human studies are observational and cannot definitively prove that microplastics cause these issues, only that they are associated. More robust, large-scale human clinical studies are needed to establish clearer causal links and quantify the specific health risks posed by microplastic exposure.